To the Point
To the Point

10.08.24

Treating Dry Eye at the Molecular Level

Jacob Lang, OD, FAAO, shares his knowledge of innovative therapies for dry eye with Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO. He discusses drugs in development that target pathways involved in ocular surface disease, such as reactive aldehyde species inhibitors, transient receptor potential receptors, and more.

View full description +

MORE EPISODES

08.13.25

Building Out a Dry Eye and Aesthetics Practice

Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Shane Swatts, OD

07.08.25

Takeways From the TFOS DEWS III Report

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO; and Vin T. Dang, OD, FAAO

06.11.25

A Lesson in Blink Mechanics and Dry Eye

Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Cory J. Lappin, OD, MS, FAAO

05.12.25

Is it Dry Eye or Corneal Pathology?

Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Bita Asghari, OD, FAAO, FSLS

04.09.25

Take Ownership of Your Career in Dry Eye

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO

03.11.25

Learn How Vitamin A Supports the Ocular Surface

Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Kaleb Abbott, OD, FAAO

02.10.25

Beware the Dry Eye Masqueraders

Jackie Garlich, OD, FAAO; Jessilin Quint, OD, MS, MBA, FAAO; and Mile Brujic, OD, FAAO

01.02.25

OSD’s Greatest Hits: 2024 Edition

Jackie Garlich, OD, FAAO, and Cecelia Koetting, OD, FAAO, Dipl ABO

Show More